MedTrace Logo

Pilocarpine Use After Kahook Goniotomy

NCT03933631 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2025-11-10

No results posted yet for this study

Summary

The goal of this study is to determine whether using pilocarpine provides added benefit to the success of combined cataract + Kahook Dual Blade (KDB) surgery.

Conditions

Interventions

DRUG

Pilocarpine

pilocarpine hydrochloride ophthalmic solution 2% (20 mg/mL)

DRUG

Prednisolone

Prednisolone acetate ophthalmic suspension 1%

DRUG

Ofloxacin

Ofloxacin Drops

Sponsors & Collaborators

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Wen-Jeng (Melissa) Yao, MD · Montefiore Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2028-06-30
Completion
2028-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03933631 on ClinicalTrials.gov